Related Experiment Video
Updated: Jan 4, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Epigenetic heterogeneity in cancer
Mingzhou Guo1,2, Yaojun Peng1, Aiai Gao1
11Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, #28 Fuxing Road, Beijing, 100853 China.
Tumor heterogeneity, especially intratumor heterogeneity (ITH), drives cancer therapy resistance. Understanding genetic and epigenetic factors of ITH is key to developing effective cancer treatments.
Area of Science:
- Oncology
- Cancer Biology
- Genetics
Background:
- Human cancers exhibit significant phenotypic and functional heterogeneity.
- Intratumor heterogeneity (ITH) refers to distinct cancer cell subpopulations within a single tumor.
- Tumor heterogeneity contributes to therapy resistance and treatment failure.
Purpose of the Study:
- To explore the role of genetic and epigenetic factors in cancer heterogeneity.
- To investigate how intratumor heterogeneity impacts cancer therapy outcomes.
- To highlight the potential of epigenetic therapy in overcoming drug resistance.
Main Methods:
- Review of existing research on cancer evolution and heterogeneity.
- Analysis of genetic mutations and epigenetic dysregulation in cancer development.
- Examination of therapeutic strategies targeting cancer heterogeneity.
Main Results:
- Clonal evolution explains the emergence of new cancer clones through mutations.
- Epigenetic dysregulation is frequent in cancer and occurs early in development.
- ITH is a major cause of cancer therapy failure and drug resistance.
Conclusions:
- Epigenetic alterations play a crucial role in cancer development and heterogeneity.
- Epigenetic therapies show promise in reversing drug resistance in heterogeneous cancers.
- Integrating genetic and epigenetic insights is essential for designing effective combination therapies.
More Related Videos
10:41An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cancers Originate from Somatic Mutations in a Single Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Inheritance of Chromatin Structures